PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FCC33
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $15,547
Award facts
- Contract value 100% obligated
- $15,547.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $15,547.28 and awarded December 31, 2025, was issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for pharmaceutical and medical supply delivery. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 2, 2026. This delivery order functions as a child contract under a significantly larger Indefinite Delivery Contract (IDC) vehicle—a $999,999,999.00 Pharmaceutical Prime Vendor Global Program IDC with the Defense Logistics Agency Troop Support Medical (contract SPE2DX) running through December 2026.
The award was funded by the Defense Logistics Agency's Medical Supply Chain division, which procures critical pharmaceutical products and medical supplies for military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical contracts with DLA and serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard. The company supplies a comprehensive range of products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The underlying IDC vehicle reflects DLA's strategic procurement approach for the forthcoming Pharmaceutical Prime Vendor Global Program Generation V, which is expected to involve multiple regional awards across several contractors.
Quick answers
Who was awarded contract SPE2D826FCC33?
SPE2D826FCC33 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on December 31, 2025.
How much is contract SPE2D826FCC33 worth?
The government has obligated $15,547 on SPE2D826FCC33.
Is contract SPE2D826FCC33 an order under another contract?
Yes. SPE2D826FCC33 is a delivery order under SPE2DX22D0019, an indefinite delivery contract.
Was contract SPE2D826FCC33 competed?
The extent of competition for SPE2D826FCC33 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award